Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 26, 2012
Edwards' ThruPort IntraClude intra-aortic occlusion device for use in patients undergoing cardiopulmonary bypass, including during mitral heart valve repair or replacement surgery using a minimally invasive approach. Edwards has CE Mark approval for European sales of the device and 510(k) clearance from the U.S. Food and Drug Administration (FDA). More: http://medgadget.com/2012/04/edwards-...